Glenn S Boehnlein Stryker Corp (SYK) insider trading activity

Glenn S Boehnlein is VP, Chief Financial Officer of STRYKER CORP. Currently has a direct ownership of 11,638 shares of SYK, which is worth approximately $4.33 Million. The most recent transaction as insider was on Mar 07, 2023, when has been sold 5,325 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.6K

126.95% 3M change

54.53% 12M change

Total Value Held $4.33 Million

Glenn S Boehnlein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2023	BUY Grant, award, or other acquisition	-	5,325 Added 40.72%	7,753 Common Stock
Feb 02 2023	SELL Open market or private sale	$6,810,911 $278.85 p/Share	24,425 Reduced 90.96%	2,428 Common Stock
Jan 11 2023	SELL Payment of exercise price or tax liability	$2,224,709 $263.81 p/Share	8,433 Reduced 23.9%	26,853 Common Stock
Jan 11 2023	BUY Exercise of conversion of derivative security	$929,105 $64.01 p/Share	14,515 Added 29.15%	35,286 Common Stock
May 01 2022	SELL Payment of exercise price or tax liability	$138,001 $241.26 p/Share	572 Reduced 3.02%	18,350 Common Stock
May 01 2022	BUY Exercise of conversion of derivative security	-	1,210 Added 6.01%	18,922 Common Stock
Mar 21 2022	SELL Payment of exercise price or tax liability	$1,100,371 $267.34 p/Share	4,116 Reduced 18.86%	17,712 Common Stock
Mar 21 2022	BUY Exercise of conversion of derivative security	-	8,723 Added 28.55%	21,828 Common Stock
Dec 21 2021	SELL Payment of exercise price or tax liability	$42,121 $247.77 p/Share	170 Reduced 1.28%	13,105 Common Stock
Dec 21 2021	BUY Exercise of conversion of derivative security	-	170 Added 1.26%	13,275 Common Stock
Dec 10 2021	SELL Open market or private sale	$721,752 $259.81 p/Share	2,778 Reduced 17.49%	13,105 Common Stock
Mar 21 2021	SELL Payment of exercise price or tax liability	$652,970 $230.0 p/Share	2,839 Reduced 15.16%	15,883 Common Stock
Mar 21 2021	BUY Grant, award, or other acquisition	-	6,401 Added 25.48%	18,722 Common Stock
Mar 01 2021	SELL Open market or private sale	$492,020 $246.01 p/Share	2,000 Reduced 13.97%	12,321 Common Stock
Dec 28 2020	SELL Open market or private sale	$478,200 $239.1 p/Share	2,000 Reduced 12.25%	14,321 Common Stock

Also insider at

INGN

Inogen Inc Healthcare

GSB